Video

Q&A With Fulton Velez From Sunovion Pharmaceuticals: Using Health Economics And Outcomes Research In Epilepsy Treatment

Author(s):

There are many factors to consider when treating patients with epilepsy, from the number of medications they take to the impact of the condition on their daily lives. All these factors can help determine their overall quality of life.

There are many factors to consider when treating patients with epilepsy, from the number of medications they take to the impact of the condition on their daily lives. All these factors can help determine their overall quality of life.

Fulton Velez, MD, MS, MBA, who serves as Director of Health Economics And Outcomes Research at Sunovion Pharmaceuticals discussed research that was done in this area during the 69th Annual Meeting of the American Epilepsy Society in Philadelphia.

Related Videos
Caroline Piatek, MD: High HCRU, Patient Concerns Highlight Great Unmet Need in wAIHA
Steven W. Pipe, MD: Supporting Gene Therapy Implementation for Hemophilia
Corinna L. Schultz, MD: Improving Sickle Cell Trait Documentation in Infancy
Sibgha Zaheer, MD: Determining Washout Period With Fitusiran, Emicizumab Transition for Hemophilia
Pavan K. (Tem) Bendapudi, MD: Large-Scale Analyses Elucidate Genetic Risk of Thrombosis
Seema Rani, MD: Examining Sleep Health in Youth With SCD
Daniel Wang: A More Appropriate Ferritin Threshold is Cost-Effective for Iron Deficiency Screening
Kimberly A. Davidow, MD: Elucidating Risk of Autoimmune Disease in Childhood Cancer Survivors
Yehuda Handelsman, MD: Insulin Resistance in Cardiometabolic Disease and DCRM 2.0 | Image Credit: TMIOA
© 2025 MJH Life Sciences

All rights reserved.